Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Pujol

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Bulletin Du Cancer|December 7, 2023
Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023Joseph Gligorov, Marc-Antoine Benderra, Xavier Barthere, et al.
Plos Genetics|January 7, 2016
Preferential Allele Expression Analysis Identifies Shared Germline and Somatic Driver Genes in Advanced Ovarian CancerNajeeb M Halabi, Alejandra Martinez, Halema Al-Farsi, et al.
Cancers|July 9, 2022
Predominance of <i>BRCA2</i> Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with <i>BRCA1</i> or <i>BRCA2</i> MutationPascal Pujol, Kevin Yauy, Amandine Coffy, et al.
Plos Genetics|February 19, 2016
Correction: Preferential Allele Expression Analysis Identifies Shared Germline and Somatic Driver Genes in Advanced Ovarian CancerNajeeb M Halabi, Alejandra Martinez, Halema Al-Farsi, et al.
Cancers|February 13, 2026
Prognostic Impact of Blood Tumor Mutational Burden in pMMR/MSS Metastatic Colorectal Cancer Assessed by FoundationOne<sup>®</sup> Liquid CDxBenoist Chibaudel, Elisabeth Carola, Hamid Mekranter, et al.
Oncogene|October 3, 2002
Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer familiesSophie Gad, Virginie Caux-Moncoutier, Sabine Pagès-Berhouet, et al.
Psycho-Oncology|June 2, 2019
Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutationsNathalie Alegre, Pierre Vande Perre, Yves Jean Bignon, et al.
Bulletin Du Cancer|October 1, 2018
[The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition]Jessica Moretta, Pascaline Berthet, Valérie Bonadona, et al.
NPJ Precision Oncology|June 3, 2026
When effective anticancer therapies are, in fact, destabilizing the tumor's Group Phenotypic CompositionFrédéric Thomas, Antoine M Dujon, Andriy Marusyk, et al.
Genes|August 6, 2021
No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in <i>BRCA1</i> or <i>BRCA2</i> Mutation FamiliesMarion Imbert-Bouteille, Carole Corsini, Marie-Christine Picot, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Bulletin Du Cancer|December 7, 2023
Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023Joseph Gligorov, Marc-Antoine Benderra, Xavier Barthere, et al.
Plos Genetics|January 7, 2016
Preferential Allele Expression Analysis Identifies Shared Germline and Somatic Driver Genes in Advanced Ovarian CancerNajeeb M Halabi, Alejandra Martinez, Halema Al-Farsi, et al.
Cancers|July 9, 2022
Predominance of <i>BRCA2</i> Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with <i>BRCA1</i> or <i>BRCA2</i> MutationPascal Pujol, Kevin Yauy, Amandine Coffy, et al.
Plos Genetics|February 19, 2016
Correction: Preferential Allele Expression Analysis Identifies Shared Germline and Somatic Driver Genes in Advanced Ovarian CancerNajeeb M Halabi, Alejandra Martinez, Halema Al-Farsi, et al.
Cancers|February 13, 2026
Prognostic Impact of Blood Tumor Mutational Burden in pMMR/MSS Metastatic Colorectal Cancer Assessed by FoundationOne<sup>®</sup> Liquid CDxBenoist Chibaudel, Elisabeth Carola, Hamid Mekranter, et al.
Oncogene|October 3, 2002
Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer familiesSophie Gad, Virginie Caux-Moncoutier, Sabine Pagès-Berhouet, et al.
Psycho-Oncology|June 2, 2019
Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutationsNathalie Alegre, Pierre Vande Perre, Yves Jean Bignon, et al.
Bulletin Du Cancer|October 1, 2018
[The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition]Jessica Moretta, Pascaline Berthet, Valérie Bonadona, et al.
NPJ Precision Oncology|June 3, 2026
When effective anticancer therapies are, in fact, destabilizing the tumor's Group Phenotypic CompositionFrédéric Thomas, Antoine M Dujon, Andriy Marusyk, et al.
Genes|August 6, 2021
No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in <i>BRCA1</i> or <i>BRCA2</i> Mutation FamiliesMarion Imbert-Bouteille, Carole Corsini, Marie-Christine Picot, et al.
Pageof 10